Other/Recall·FDA Recalls, Market Withdrawals & Safety Alerts

Total Nutrition Inc. Expands Recall of TNVitamins and Doctor’s Pride Ultra Potent Complete Green Superfood Moringa Capsules Because of Possible Health Risk Following Further Supply Chain Review

MediumPublished Jun 11, 2026· AI-analyzed Jun 12, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Total Nutrition Inc. has expanded its voluntary recall of TNVitamins and Doctor’s Pride Ultra Potent Complete Green Superfood Moringa Capsules due to potential Salmonella contamination identified during a supply chain investigation.

Who it affects

This recall affects Total Nutrition Inc., distributors of TNVitamins and Doctor's Pride brands, and quality assurance personnel responsible for botanical supplement safety and supply chain verification.

Why it matters

The expansion of a recall based on a supply chain review indicates that initial mitigation efforts may not have captured the full scope of the contamination. This suggests that the underlying issue may be linked to a specific raw material supplier or a shared production process, highlighting the necessity for robust supplier qualification and traceability protocols in the dietary supplement industry.

Practical takeaway

Quality and compliance teams should verify the integrity of their raw material supply chains, particularly for botanical ingredients. In the event of a contamination signal, firms should be prepared to conduct a comprehensive look-back analysis to determine if additional lots or brands are implicated by the same source material.

FDA source material

Total Nutrition Inc. of Deer Park, NY is voluntarily expanding its recall of TNVitamins and Doctor's Pride Ultra Potent Complete Green Superfood Moringa Capsules due to the potential to be contaminated with Salmonella. This expansion follows an ongoing supply chain investigation that identified addi

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.